NZ238032A - (-)-1-(4'-amino-3'-cyanophenyl)-2-isopropylaminoethanol; preparation, pharmaceutical compositions and animal feedstuffs - Google Patents

(-)-1-(4'-amino-3'-cyanophenyl)-2-isopropylaminoethanol; preparation, pharmaceutical compositions and animal feedstuffs

Info

Publication number
NZ238032A
NZ238032A NZ238032A NZ23803291A NZ238032A NZ 238032 A NZ238032 A NZ 238032A NZ 238032 A NZ238032 A NZ 238032A NZ 23803291 A NZ23803291 A NZ 23803291A NZ 238032 A NZ238032 A NZ 238032A
Authority
NZ
New Zealand
Prior art keywords
acid
tartaric acid
compound
dibenzoyl
amino
Prior art date
Application number
NZ238032A
Other languages
English (en)
Inventor
Wolfgang Resemann
Adolf Durr
Gunther Engelhardt
John Francis Quirke
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of NZ238032A publication Critical patent/NZ238032A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
NZ238032A 1990-05-04 1991-05-03 (-)-1-(4'-amino-3'-cyanophenyl)-2-isopropylaminoethanol; preparation, pharmaceutical compositions and animal feedstuffs NZ238032A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (1)

Publication Number Publication Date
NZ238032A true NZ238032A (en) 1996-02-27

Family

ID=6405664

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ238032A NZ238032A (en) 1990-05-04 1991-05-03 (-)-1-(4'-amino-3'-cyanophenyl)-2-isopropylaminoethanol; preparation, pharmaceutical compositions and animal feedstuffs

Country Status (27)

Country Link
US (4) US5248695A (enExample)
EP (2) EP0455155B1 (enExample)
JP (1) JP2944777B2 (enExample)
KR (1) KR0183024B1 (enExample)
AR (1) AR247728A1 (enExample)
AT (2) ATE124932T1 (enExample)
AU (1) AU645313B2 (enExample)
BG (1) BG60743B1 (enExample)
CA (1) CA2041818C (enExample)
CZ (1) CZ286389B6 (enExample)
DE (3) DE4014252A1 (enExample)
DK (2) DK0455155T3 (enExample)
ES (2) ES2109412T3 (enExample)
FI (1) FI109600B (enExample)
GR (2) GR3017064T3 (enExample)
HU (1) HU214335B (enExample)
ID (1) ID966B (enExample)
IE (2) IE69017B1 (enExample)
IL (1) IL98030A (enExample)
NO (1) NO174803B (enExample)
NZ (1) NZ238032A (enExample)
PT (1) PT97544B (enExample)
RU (1) RU2002737C1 (enExample)
SG (1) SG45439A1 (enExample)
SK (1) SK279258B6 (enExample)
TW (1) TW197415B (enExample)
ZA (1) ZA913337B (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
EP0892639A4 (en) * 1996-01-29 1999-06-09 Savor Evelyn PROCESS FOR THE TREATMENT OF UNWANTED UTERINE CONTRACTIONS USING OPTICALLY PURE R OR RR ISOMERS OF AGONIST -g (b) -2 ADRENERGIC AGONISTS
EP0979081A4 (en) 1997-04-30 2003-05-02 Bridge Pharma Inc COMPOSITION AND METHODS USING EUTOMER
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
RU2201420C2 (ru) * 1998-11-03 2003-03-27 Новартис Аг Нитрилы дипептидов
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
HUP0300832A2 (hu) * 2000-04-27 2003-08-28 Boehringer Ingelheim Pharma Gmbh & Co. Kg Új, lassú hatású bétamimetikumok, eljárás előállításukra és alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
WO2004103057A2 (en) * 2003-05-15 2004-12-02 The University Of Georgia Research Foundation, Inc. Compositions and methods for inducing adipose tissue cell death
DK1663197T3 (da) * 2003-09-09 2008-01-07 Fumapharm Ag Anvendelse af fumarsyrederivater til behandling af hjerteinsuffiens og astma
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
WO2006108424A2 (en) * 2005-04-13 2006-10-19 Astion Pharma A/S Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
WO2006128180A2 (en) * 2005-05-27 2006-11-30 Children's Medical Center Corporation Methods for the treatment of disease
US20090305225A1 (en) * 2005-06-13 2009-12-10 Galbraith Richard A Inhibition of Creatine Uptake to Promote Weight Loss
RU2408014C2 (ru) * 2009-03-10 2010-12-27 Государственное образовательное учреждение высшего профессионального образования "Российский государственный медицинский университет им. Н.И. Пирогова Министерства здравоохранения и социального развития Российской Федерации" Способ прогнозирования преждевременных родов инфекционного генеза
MY176727A (en) 2012-12-03 2020-08-20 Pfizer Selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (enExample) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
IE80651B1 (en) 1998-11-04
CA2041818C (en) 2003-02-11
JPH04225944A (ja) 1992-08-14
EP0455155A1 (de) 1991-11-06
CS129291A3 (en) 1991-11-12
NO174803C (enExample) 1994-07-13
NO911746L (no) 1991-11-05
NO174803B (no) 1994-04-05
GR3017064T3 (en) 1995-11-30
IE911507A1 (en) 1991-11-06
KR910019966A (ko) 1991-12-19
JP2944777B2 (ja) 1999-09-06
US5248695A (en) 1993-09-28
US5648386A (en) 1997-07-15
AR247728A1 (es) 1995-03-31
HUT60999A (en) 1992-11-30
ZA913337B (en) 1993-01-27
DE4014252A1 (de) 1991-11-07
PT97544B (pt) 1998-08-31
SK279258B6 (sk) 1998-08-05
FI912151L (fi) 1991-11-05
US5292753A (en) 1994-03-08
BG94342A (en) 1994-06-30
ES2075255T3 (es) 1995-10-01
DE59108853D1 (de) 1997-10-23
PT97544A (pt) 1992-01-31
CA2041818A1 (en) 1991-11-05
FI109600B (fi) 2002-09-13
BG60743B1 (bg) 1996-02-29
NO911746D0 (no) 1991-05-03
DK0455155T3 (da) 1995-11-13
TW197415B (enExample) 1993-01-01
US5395957A (en) 1995-03-07
SG45439A1 (en) 1998-01-16
FI912151A0 (fi) 1991-05-03
EP0455155B1 (de) 1995-07-12
DE59105957D1 (de) 1995-08-17
HU214335B (hu) 1998-03-02
HU911502D0 (en) 1991-11-28
EP0589488A1 (de) 1994-03-30
EP0589488B1 (de) 1997-09-17
KR0183024B1 (ko) 1999-05-15
RU2002737C1 (ru) 1993-11-15
ID966B (id) 1996-09-30
CZ286389B6 (cs) 2000-03-15
IL98030A0 (en) 1992-06-21
AU7611191A (en) 1991-11-07
IL98030A (en) 1995-12-31
IE69017B1 (en) 1996-07-24
ES2109412T3 (es) 1998-01-16
ATE158277T1 (de) 1997-10-15
ATE124932T1 (de) 1995-07-15
DK0589488T3 (da) 1998-05-04
GR3025547T3 (en) 1998-03-31
AU645313B2 (en) 1994-01-13

Similar Documents

Publication Publication Date Title
AU645313B2 (en) Improved process for resolution of racemic cimaterol;(-)- cimaterol and derivatives thereof
US5232946A (en) Phenylethanolamines, their use as pharmaceuticals and as performance enhancers in animals
EP0026298B1 (en) Method for promoting growth and reducing fat in animals using phenylethanolamine derivatives
US4287201A (en) Anovulatory method and chicken feed compositions
BG60752B2 (bg) Метод за повишаване растежа на животни с фенеталови амини
US5393774A (en) Phenylethanolamines, pharmaceutical compositions containing these compounds and process for preparing them
JPS60168349A (ja) 抗微生物性動物飼料添加物組成物
AU621587B2 (en) Use of thiazoles for improving performance in animals
DE3636605A1 (de) Verfahren zur trennung der enantiomeren von 1-(4-amino-3,5-dichlorphenyl)-2-(tert.-butyl) -hydroxy-amino-ethanol sowie deren verwendung als leistungsfoerderer bei tieren
IE56844B1 (en) Phenethanolamine derivatives in weight control in animals
CS236477B2 (cs) Prostředek vhodný pro povzbuzení rychlosti růstu a pro snížení ukládání tuku u teplokrevných zvířat